Should You Own Emerging-Market Stocks? The Case for Market Weight

Two Questions, Not One

The emerging-markets debate usually collapses two separate questions into one argument. The first question is whether EM stocks belong in a diversified portfolio at all. The second is whether to hold more or less of them than their share of the global market. The first has a boring, well-supported answer: yes, at market weight, which is what you get automatically inside a total-world index fund. The second is a judgment call, and the answer depends more on your behavior than on anyone's forecast.

Bulls argue that fast-growing economies must produce high stock returns. Bears point at the 2010s, when EM lagged the S&P 500 by nearly 10 percentage points a year. Both arguments fail for the same reason: they treat a single decade, or a single growth statistic, as the whole story.

What Emerging-Market Stocks Actually Are

Emerging markets is an index-classification term, defined by criteria like market accessibility, liquidity, and economic development, and decided by index providers rather than economists. As of the May 29, 2026 MSCI ACWI IMI factsheet, the global investable index spans 23 developed and 24 emerging markets with 8,216 constituents covering roughly 99% of the world equity opportunity set. The EM list includes China, India, Taiwan, Korea, Brazil, Saudi Arabia, Mexico, Indonesia, and South Africa.

The EM index is a free-float-weighted portfolio of listed companies: chipmakers, banks, internet platforms, commodity producers, exporters. It is not a claim on the GDP of the developing world. Taiwan Semiconductor alone is a top-ten holding of the entire global index, larger than most developed-market companies. Whatever you believe about emerging economies, what you actually buy is a basket of specific businesses at specific prices.

Emerging markets currently make up about 12.35% of the MSCI ACWI (May 2026). That number is the neutral position. Everything above or below it is a tilt.

The Growth Argument Fails on the Evidence

The most common case for overweighting EM is that developing economies grow faster, so their stocks should return more. The evidence says otherwise, and not by a little. Why the Stock Market Is Not the Economy covers the general result; the EM-specific version is stronger.

In Triumph of the Optimists, Dimson, Marsh, and Staunton documented a negative correlation between countries' real per-capita GDP growth and their real stock returns over 1900-2000. Hsu, Ritter, Wool, and Zhao (2022) updated the analysis across 15 emerging and 21 developed markets with samples up to 120 years and confirmed that GDP growth is an unreliable cross-sectional predictor of returns. What does predict returns is growth in earnings per share and dividends per share, the growth that actually reaches shareholders.

GDP growth appears nowhere in that decomposition, and several mechanisms break the link between an economy and its listed market. Companies issue new shares, so per-share earnings grow slower than aggregate profits. State-owned enterprises and controlling insiders can capture gains before minority shareholders see them. Much of a fast-growing economy is private or unlisted. Currency depreciation can erase local gains for a dollar-based investor. And a market everyone knows is growing tends to be priced for it before you arrive.

The Record: Two Decades, Two Opposite Stories

Annualized total returns in U.S. dollars, computed from annual index data:

During the S&P 500's lost decade, EM compounded at 10% a year. During the U.S. bull market that followed, EM delivered a third of the S&P's return with more volatility. An investor who extrapolated either decade into the next one was badly wrong both times. The pattern has continued: after lagging for most of the 2010s, the MSCI EM IMI returned 31.4% in 2025 and 51.1% over the twelve months ending May 2026, per the MSCI factsheet.

Over the full ten years through May 2026, EM IMI returned 10.6% annualized against 12.8% for developed markets, with higher volatility (17.2% vs 15.1%) and a lower Sharpe ratio (0.53 vs 0.72). Its worst drawdown, 65% in 2007-2008, exceeded the developed-market index's 58%. The case for EM cannot rest on superior past performance, because over most recent windows it was not superior.

Diversification is the defensible claim, with one qualifier from the academic literature. Bekaert and Urias documented the original diversification case while showing the benefit shrinks once you account for what investors can actually buy. Bekaert, Harvey, and Mondino find EM still behaves as a distinct asset class, but globalization has raised its correlation with developed markets. EM diversifies an equity portfolio across countries, currencies, and profit sources. It does not hedge it. In a global crash, EM falls too, usually harder.

The Risks Are Different in Kind, Not Just Size

Bekaert and Harvey's survey of emerging-markets finance catalogs the risks that do not show up in a volatility number: weaker investor protections, lower accounting quality, political and policy risk, illiquidity, capital controls, and time-varying integration with world markets.

Russia made the catalog concrete. In March 2022, after sanctions and capital controls made the market untradeable for foreigners, MSCI removed Russian securities from its Emerging Markets indexes at a price of effectively zero. Index investors holding Russia at its roughly 3% EM weight lost that slice outright. Diversification did its job in the narrow sense (3% of the EM sleeve, a fraction of a percent of a global portfolio), and the episode is a standing reminder that the EM risk premium exists because the risks are real.

The Valuation Case, Stated Carefully

From the same May 2026 MSCI factsheet:

EM trades at roughly a third less than developed markets on forward earnings, even after its 50% one-year run. Some of that gap is compensation for the governance, currency, and access risks above. Some of it may be excess pessimism. Nobody can tell you the split in advance, and cheap markets can stay cheap for structural reasons. Valuation supports owning EM at market weight and makes a modest overweight defensible; it does not make EM a sure thing on any horizon you can schedule. See Do Valuations Still Matter? for why valuation works slowly when it works at all.

Market Weight, Overweight, Underweight, or Zero

No row in that table is justified by a growth forecast. The defensible reasons to deviate from market weight are valuation discipline and self-knowledge.

Zero deserves one more sentence, because it is the most common allocation in practice. A U.S.-only portfolio is not a neutral choice; it is a concentrated bet that the country with 62% of global market cap and the most expensive valuations keeps winning. Vanguard's guidance suggests about 40% of a stock allocation in international stocks, and a market-weight EM sleeve comes along with that automatically. The Case for Global Equity Diversification makes the full argument.

The Behavioral Test Decides the Right Weight

Whatever weight you choose, the 2010s are the qualifying exam. EM returned 4% a year while the S&P returned 13.6%, for ten straight years. An investor who held market weight through that stretch and rebalanced ended up positioned for 2025's 31% EM year. An investor who capitulated in 2019, after a decade of pain and at the bottom of the relative cycle, converted temporary underperformance into a permanent loss and then missed the recovery.

Performance-chasing runs in both directions. Abandoning EM after the 2010s was chasing; piling in after a 51% trailing year is also chasing. A written allocation with mechanical rebalancing is the defense against both. The right EM weight is the largest one you can hold through a decade that looks like the 2010s, which for many investors is simply the weight already embedded in their total-world fund, where the decision never surfaces as a separate line item to agonize over.

Implementation: The Boring Options Are Good Now

Owning EM at market weight costs almost nothing today. A total-world fund like VT (0.06% expense ratio) includes EM at market weight with zero maintenance. A total-international fund holds it inside the ex-US sleeve. Dedicated EM funds for sleeve-builders include VWO (0.06%) and IEMG (0.09%), each holding thousands of securities. Factor-tilted options like AVES (0.36%) cost more and add a value tilt on top of the EM decision; that is two active choices stacked, which is fine as long as you made both on purpose. One construction detail worth knowing: FTSE indexes (VWO) classify Korea as developed while MSCI (IEMG) classifies it as emerging, so mixing index families can double-count or drop a top-five market.

Check before you buy a dedicated EM fund: you may already own EM. A total-international fund is typically about a quarter EM, and a total-world fund holds it at market weight. Adding a sleeve on top of either is an overweight, whether intended or not.

What the Evidence Supports

• EM stocks belong in a diversified portfolio at their market weight, about 12% of global equities, because they are a large, imperfectly correlated part of the investable world. That case needs no growth forecast.
• The growth story is the weakest reason to own them: GDP growth has no reliable cross-country link to stock returns, and the mechanisms behind the disconnect (dilution, insider capture, unlisted growth, currency) are strongest in emerging markets.
• The case that survives the evidence is risk compensation: a forward P/E of 12 versus 19 for developed markets, paired with governance, currency, and access risks that occasionally realize in full, as Russia 2022 showed.
• Decade-scale reversals (EM +10%/yr while the U.S. lost money, then the mirror image) are the norm, which makes both performance-chasing and performance-fleeing expensive.
• Deviations from market weight should be sized by what you can hold through a 2010s-style drought, written down, and rebalanced mechanically.

Frequently Asked Questions

Do I already own emerging markets?

If you hold a total-world fund (VT, ACWI), yes, at market weight. If you hold a total-international fund (VXUS, IXUS), yes, at roughly a quarter of that fund. If you hold only U.S. funds (VTI, VOO, VTSAX), no, and foreign revenue of U.S. companies does not substitute; domicile drives stock behavior, not revenue mix.

Is now a good time to buy emerging markets?

Unanswerable on the timing, which is the point of market weight. EM is cheaper than developed markets on every standard multiple and has also just returned 51% in twelve months; the valuation signal and the momentum signal point in opposite directions for a market-timer. An allocation policy with rebalancing does not need to resolve that argument.

Is EM riskier than U.S. stocks?

Yes, by most measures: higher volatility (17.2% vs 15.1% over ten years), deeper drawdowns (65% vs 58% in the financial crisis), plus risks that volatility does not capture, like capital controls and sanctions. The compensation is a lower price for the same dollar of earnings. Whether that trade is attractive at 12% of your equities is a different question from whether it would be at 40%.

How much EM is too much?

A useful ceiling is the point where a 2010s repeat would make you abandon the plan. For most investors that lands somewhere between market weight (~12% of equities) and roughly double it. Beyond that, single-sleeve risk starts dominating the portfolio: a 25%+ EM allocation turned the 2010s into a lost decade for the entire equity portfolio rather than for one sleeve of it.

Related Guides

• The Case for Global Equity Diversification makes the broader own-the-world argument this guide builds on.
• Why the Stock Market Is Not the Economy covers the GDP-vs-returns evidence in full.
• But What About Japan? shows what single-country concentration costs when a market loses three decades.
• Do Valuations Still Matter? explains why cheap markets reward patience on no particular schedule.
• Fama-French Factors covers the factor lens behind tilted EM funds like AVES.
• The Simplified Engineer Investor Portfolio shows a concrete three-fund implementation with global exposure.